Moreover, our results show that DT-061 modulation of PP2A regulates TFE3 to promote ATF4 expression and activity in both cancer and non-malignant cells, albeit distinctive downstream response mechanisms are activated, resulting in two distinct outcomes. The gene discussed is ATF4; the disease is cancer.